Literature DB >> 25070415

The use of mode of action information in risk assessment: quantitative key events/dose-response framework for modeling the dose-response for key events.

Ted W Simon1, S Stoney Simons, R Julian Preston, Alan R Boobis, Samuel M Cohen, Nancy G Doerrer, Penelope A Fenner-Crisp, Tami S McMullin, Charlene A McQueen, J Craig Rowlands.   

Abstract

The HESI RISK21 project formed the Dose-Response/Mode-of-Action Subteam to develop strategies for using all available data (in vitro, in vivo, and in silico) to advance the next-generation of chemical risk assessments. A goal of the Subteam is to enhance the existing Mode of Action/Human Relevance Framework and Key Events/Dose Response Framework (KEDRF) to make the best use of quantitative dose-response and timing information for Key Events (KEs). The resulting Quantitative Key Events/Dose-Response Framework (Q-KEDRF) provides a structured quantitative approach for systematic examination of the dose-response and timing of KEs resulting from a dose of a bioactive agent that causes a potential adverse outcome. Two concepts are described as aids to increasing the understanding of mode of action-Associative Events and Modulating Factors. These concepts are illustrated in two case studies; 1) cholinesterase inhibition by the pesticide chlorpyrifos, which illustrates the necessity of considering quantitative dose-response information when assessing the effect of a Modulating Factor, that is, enzyme polymorphisms in humans, and 2) estrogen-induced uterotrophic responses in rodents, which demonstrate how quantitative dose-response modeling for KE, the understanding of temporal relationships between KEs and a counterfactual examination of hypothesized KEs can determine whether they are Associative Events or true KEs.

Entities:  

Keywords:  Q-KEDRF; associative event; key event; mode of action; modulating factor; risk assessment

Mesh:

Substances:

Year:  2014        PMID: 25070415     DOI: 10.3109/10408444.2014.931925

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  14 in total

1.  Demodifying RNA for Transcriptomic Analyses of Archival Formalin-Fixed Paraffin-Embedded Samples.

Authors:  Leah C Wehmas; Charles E Wood; Remi Gagne; Andrew Williams; Carole Yauk; Mark M Gosink; Deidre Dalmas; Ruixin Hao; Raegan O'Lone; Susan Hester
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

2.  The structural basis of modified nucleosome recognition by 53BP1.

Authors:  Marcus D Wilson; Samir Benlekbir; Amélie Fradet-Turcotte; Alana Sherker; Jean-Philippe Julien; Andrea McEwan; Sylvie M Noordermeer; Frank Sicheri; John L Rubinstein; Daniel Durocher
Journal:  Nature       Date:  2016-07-27       Impact factor: 49.962

3.  From the Cover: Genomic Effects of Androstenedione and Sex-Specific Liver Cancer Susceptibility in Mice.

Authors:  John P Rooney; Natalia Ryan; Brian N Chorley; Susan D Hester; Elaina M Kenyon; Judith E Schmid; Barbara Jane George; Michael F Hughes; Yusupha M Sey; Alan Tennant; Denise K MacMillan; Jane Ellen Simmons; Charlene A McQueen; Arun Pandiri; Charles E Wood; J Christopher Corton
Journal:  Toxicol Sci       Date:  2017-11-01       Impact factor: 4.849

4.  A model for aryl hydrocarbon receptor-activated gene expression shows potency and efficacy changes and predicts squelching due to competition for transcription co-activators.

Authors:  Ted W Simon; Robert A Budinsky; J Craig Rowlands
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

5.  Key Elements for Judging the Quality of a Risk Assessment.

Authors:  Penelope A Fenner-Crisp; Vicki L Dellarco
Journal:  Environ Health Perspect       Date:  2016-02-05       Impact factor: 9.031

Review 6.  Application of Adverse Outcome Pathways to U.S. EPA's Endocrine Disruptor Screening Program.

Authors:  Patience Browne; Pamela D Noyes; Warren M Casey; David J Dix
Journal:  Environ Health Perspect       Date:  2017-09-01       Impact factor: 9.031

Review 7.  Critical role of toxicologic pathology in a short-term screen for carcinogenicity.

Authors:  Samuel M Cohen; Lora L Arnold
Journal:  J Toxicol Pathol       Date:  2016-05-23       Impact factor: 1.628

Review 8.  The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation.

Authors:  Antone L Brooks; David G Hoel; R Julian Preston
Journal:  Int J Radiat Biol       Date:  2016-06-07       Impact factor: 2.694

9.  Integration of novel approaches demonstrates simultaneous metabolic inactivation and CAR-mediated hepatocarcinogenesis of a nitrification inhibitor.

Authors:  Jessica L LaRocca; Reza J Rasoulpour; B Bhaskar Gollapudi; David L Eisenbrandt; Lynea A Murphy; Matthew J LeBaron
Journal:  Toxicol Rep       Date:  2017-10-28

10.  Assessment of Perceptions and Cancer Risks of Workers at a Polychlorinated Biphenyl-Contaminated Hotspot in Ethiopia.

Authors:  Sisay Abebe Debela; Ishmail Sheriff; Endashaw Abebe Debela; Musa Titus Sesay; Alemu Tolcha; Michaela Sia Tengbe
Journal:  J Health Pollut       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.